Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts

Journal of Cellular Biochemistry

Volumn 68, Issue 2, 1998, Pages 269-280

  Beck Jr , George R ^a   Sullivan, Elizabeth Carlson ^b   Moran, Elizabeth ^a   Zerler, Brad ^b,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYER CORPORATION   (United States)

^c CollaGenex Pharmaceuticals Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOPONTIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

3T3 CELLS; ADENOVIRUS E1A PROTEINS; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; COLLAGEN; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, VIRAL; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PHENOTYPE; RNA; SIALOGLYCOPROTEINS; VARIATION (GENETICS);

ADENOVIRIDAE; ANIMALIA;

EID: 2642678477     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A     Document Type: Article

References (53)

1. Arany Z, Sellers WR, Livingston DM, Eckner R (1994): E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
2. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R (1995): A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81-84.
3. Aubin JE, Liu F (1996): The osteoblast lineage. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 51-67.
4. Aubin JE, Turksen K, Heersche JNM (1993): Osteoblastic cell lineage. In M. Noda (ed): "Cellular and Molecular Biology of Bone." San Diego: Academic Press, pp 1-45.
5. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1993): "Current Protocols in Molecular Biology" New York: John Wiley & Sons, 9.1.1-9.1.9, 9.5.1-9.5.6.
6. Avantagiatti ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997): Recruitment of p300/CBP in p53 dependent pathways. Cell 89:1175-1184.
7. Bayley ST, Mymryk JS (1994): Adenovirus E1A proteins and transformation. [Review.] Int J Oncol 5:425-444.
8. Bellows CG, Aubin JE, Heersche JNM (1991): Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 14:27-40.
9. Butler WT, Ridall AL, McKee MD (1996): Osteopontin. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 167-181.
10. Chakravarti D, La Morte V, Nelson M, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans R (1996): Role of CBP/p300 in nuclear receptor signalling. Nature 383: 99-103.
11. Choi JY, Lee BH, Song KB, Park RW, Kim IS, Sohn KY, Yo JS, Ryoo HM (1996): Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3 E1 cells. J Cell Biol 61:609-618.
12. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH (1993): Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
13. Cress WD, Nevins JR (1996): Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Curr Topics Microbiol Immunol 208:63-78.
14. Dallas PB, Yaciuk P, Moran E (1997): Characterization of monoclonal antibodies raised against p300: Both p300 and CBP are present in intracellular TBP complexes. J Virol 71:1726-1731.
15. Eckner R (1996): p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol Chem 377:685-688.
16. Eckner R, Ewen ME, Newsome D, DeCaprio JA, Lawrence JB, Livingstone DM (1994): Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kd protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8:869-884.
17. Eckner R, Yao TP, Oldread E, Livingston DM (1996): Interaction and functional collaboration of p300/CBP and BHLH proteins in muscle and B-cell differentiation. Genes Dev 10:2478-2490.
18. Fedde KN, Michell MP, Henthorn PS, Whyte MP (1996): Aberrant properties of alkaline phosphatase in patient fibroblasts correlate with clinical expressivity in severe forms of hypophosphatasia. J Clin Endocrinol Metab 81:2587-2594.
19. Franceschi RT, Iyer BS (1992): Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7:235-246.
20. Franceschi RT, Iyer BS, Cui Y (1994): Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 9:843-854.
21. Graña X, Reddy EP (1995): Cell cycle control in mammalian cells: Cyclin-dependent kinases, growth suppressor genes, and cyclin-dependent kinase inhibitors. Oncogene 11:211-219.
22. Gronowicz G, Raisz LG (1996): Bone formation assays. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 1253-1265.
23. Gu W, Shi X-L, Roeder RG (1997): Synergistic activation of transcription by CBP and p53. Nature 387:819-822.
24. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L (1983): Isolation and characterization of full-length cDNA clones for human α-, β-and γ-actin mRNA's: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 3:787-795.
25. Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M (1996): p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11540-11545.
26. Harlow E, Lane D (1988): "Antibodies: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
27. Hauschka PV, Lian JB, Cole DEC, Gundberg CM (1989): Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047.
28. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld M (1996): A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
29. Liau G, Yamada Y, deCrombrugghe B (1985): Coordinate regulation of the levels of type III and type I collagen mRNAin most but not all mouse fibroblasts. J Biol Chem 260:531-536.
30. Lill NL, Grossman SR, Ginsburg D, DeCaprio J, Livingston DM (1997): Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
31. Lundblad JR, Kwok RPS, Laurance ME, Harter ML, Goodman RH (1995): Adenoviral E1A-associated protein p300 as a functional homogue of the transcriptional co-activator CBP. Nature 374:85-88.
32. Marsh ME, Munne AM, Vogel JJ, Cui Y, Franceschi RT (1995): Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. J Bone Miner Res 10:1635-1643.
33. McKee MD, Nanci A (1996): Osteopontin at mineralization tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Technol 33:141-164.
34. McVey JH, Nomura S, Kelly P, Mason IJ, Hogan BL (1988): Characterization of the mouse SPARC/osteonectin gene. J Biol Chem 263:11111-11116.
35. Moran E (1994): Cell growth control mechanisms reflected through protein interactions with the adenovirus E1A gene products. Semin Virol 5:327-340.
36. Moran E, Zerler B (1988): Interactions between cell growth regulating domains in the products of the adenovirus ElAoncogene. Mol Cell Biol 8:1756-1764.
37. Quarles D, Yohay DA, Lever LW, Caton R, Wenstrup RJ (1992): Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Miner Res 7:683-692.
38. Robey PG (1996): Bone matrix proteoglycans and glycoproteins. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 155-165.
39. Sartorelli V, Huang J, Hamamori Y, Kedes L (1997): Molecular mechanisms of myogenic coactivation by p300 -Direct interaction with the activation domain of MyoD and with the MADS Box of MEF2C. Mol Cell Biol 17: 1010-1026.
40. Scolnick DM, Chehab N, Stavridi ES, Lien M, Caruso L, Moran E, Berger SL, Halazonetis TD (1997): CBP and P/CAF are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res 57:3693-3696.
41. Southern PJ, Berg P (1982): Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1:327-341.
42. Stein GS, Lian JB, Stein JL, van Wijnen AJ, Frenkel B, Montecino M (1996): Mechanisms regulating osteoblast proliferation and differentiation. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 69-86.
43. Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E (1990): Analysis of E1A-mediated growth regulation functions: Binding of the 300 kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis inducing activity. J Virol 64:4421-4427.
44. Sudo H, Kodama H, Amagi Y, Yamamoto S, Kasai S (1983): In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198.
45. Terao M, Studer M, Gianni M, Garattini E (1990): Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. Biochemistry 268:641-648.
46. Tong H-S, Sakai DD, Sims SM, Dixon J, Yamin M, Goldring SR, Snead ML, Minkin C (1994): Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotyping. J Bone Miner Res 9:577-584.
47. Wang H-GH, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B, Moran E (1993): Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and the control of cell growth. J Virol 67:476-488.
48. Wang H-GH, Zerler B, Moran E (1996): DNA tumor viruses: Adenovirus. In Bertino JR (ed): "Molecular Biology of Cancer." Vol. I. San Diego: Academic Press, pp 508-519.
49. Wenstrup RJ, Fowlkes JL, Witte DP, Florer JB (1996): Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrix. J Biol Chem 271:10271-10276.
50. Whyte MP (1994): Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439-461.
51. Whyte MP (1996): Hypophosphatasia: Nature's window on alkaline phosphatase in man. In Bilezikian JP, Raisz LG, Rodan GA (eds): "Principles of Bone Biology." San Diego: Academic Press, pp 951-968.
52. Young MF, Ibaraki K, Kerr JM, Heegaard A-M (1993): Molecular and cellular biology of the major noncollagenous proteins in bone. In "Cellular and Molecular Biology of Bone." San Diego: Academic Press, pp 1-45.
53. Yuan W, Condorelli G, Caruso M, Falsani A, Giordano A (1996): Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 271:9009-9013.